[ad_1]
Get inside Wall Road with StreetInsider Premium. Declare your 1-week free trial here.
Denver, Colorado–(Newsfile Corp. – July 13, 2021) – CBD of Denver, Inc. (OTC Pink: CBDD), a full-line CBD and hemp oil firm and a producer and distributor of hashish and CBD merchandise in Switzerland and Europe, via its Rockflowr division, is actively negotiating with strategic companions to place the Firm to fulfill the anticipated surge in demand for medical hashish in Switzerland as authorities pilot initiatives for managed distribution launch in early 2022.
“The Federal Workplace of Public Well being expects a number of tons of product might be wanted to fulfill preliminary demand. This may very well be one other income and revenue enhance for our Swiss enterprise whereas fortifying our total basis throughout Europe,” commented Marcel Gamma, CEO of CBD of Denver. “Constructing on our observe file of robust progress, I imagine we’re nicely positioned to play a serious position on this new and sizeable market alternative.”
CBD of Denver is in discussions to ship product through its present licenses for Switzerland.
Observe CBDD on Instagram: @CBDofDenver_Inc, @Rockflowr, @RockflowrRetail
CBD of Denver, Inc., Rockflowr GmbH and Swiss Trade Ventures AG at the moment are additionally on LinkedIn.
About CBD of Denver, Inc.
CBD of Denver, Inc. (OTC Pink: CBDD) a full-line CBD and Hemp oil firm (“CBDD”) and a producer and distributor of Hashish and CBD merchandise in Switzerland and Europe. CBDD is targeted on utilizing fairness to accumulate worthwhile Swiss belongings at enticing valuations to create worth for all our shareholders pushed by a ardour to enhance lives and strengthen communities by unleashing the complete potential of hashish.
Via our model Rockflowr and BlackPearlCBD we attain our shoppers and have constructed up a powerful buyer base by specializing in high-quality merchandise and significant buyer relationships.
Black Pearl CBD has 0% THC however just isn’t an Isolate the place the THC is stripped from the product rendering it ineffective. We use a proprietary method including terpenes because the activation ingredient, leading to a product that’s the best within the business and solely out there at www.cbdofdenver.com.
Info contained herein contains forward-looking statements. These statements relate to future occasions or future monetary efficiency, involving recognized and unknown dangers and you shouldn’t place undue reliance on these statements. Any forward-looking assertion displays our present views with respect to future occasions. We assume no obligation publicly about replace or revise these forward-looking statements for any cause.
Contacts:
Investor Relations
investors@cbdofdenver.com
Marcel Gamma
marcel@cbdofdenver.com
Todd McKnight
RedChip Firms
1-800-733-2447
todd@redchip.com
To view the supply model of this press launch, please go to https://www.newsfilecorp.com/release/90088
[ad_2]
Source link
